| Financial Year |
March 31 2023 |
| Monetary Funds |
132,784,256.77 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
40,926.00 |
| Advances to Suppliers |
2,099,013.52 |
| Other Receivables |
914,960.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
35,073,492.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
92,066,303.58 |
| Total Current Assets |
262,978,952.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
193,054,813.95 |
| Under-construction Projects |
379,528,066.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
129,964,930.05 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,893,444.20 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
718,622,387.29 |
| Total Assets |
981,601,340.22 |
| Short-Term Loans |
30,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
49,855,056.76 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,599,238.55 |
| Taxes Payable |
185,007,788.89 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
339,739,482.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,160,317.45 |
| Other Current Liabilities |
6,825,726.79 |
| Sub-Total of Current Liabilities |
666,132,442.86 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,897,975.38 |
| Total Liabilities |
672,030,418.24 |
| Paid-In Capital(Or Share Stock) |
356,400,000.00 |
| Capital Surplus |
68,827,234.77 |
| Surplus Reserve |
198,312,245.93 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-263,036,418.89 |
| Minority Stockholder's Interest |
-50,932,139.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
360,503,061.81 |
| Owner's Equity（Stockholder's Equity） |
309,570,921.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
981,601,340.22 |
